CCO Oncology Podcast

Jan 08 2025 186 ep. 22 mins 84
CCO Oncology Podcast artwork

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

  Education  Health & Fitness  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer

Jan 08 2025 36 mins  
Audio podcast with key highlights on current and emerging data for the use of oral SERDS in patients with HR+/HER2- ESR1-mutated advanced breast cancer. Listen to experts put new trial results into context and cover practical perspectives and takeaway points for your everyday practice.

Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies

Oct 22 2024 20 mins  
Caitlin Costello, MD, discusses the role and safety of bispecific antibodies approved for the treatment of relapsed/refractory multiple myeloma as well as emerging data and clinical trials with this treatment approach.

Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations

Oct 16 2024 28 mins  
Listen as Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss the diagnosis and typical presenting symptoms of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as findings from recent phase III studies including NETTER-2 and CABINET. Notable clinical pearls regarding GEP-NET therapies and current guidelines for GEP-NET care and monitoring are also highlight

ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers

Oct 01 2024 30 mins  
Audio podcast with key clinical highlights for gynecologic cancers from the 2024 ESMO congress. Listen to experts put new trial results into context and share their perspectives and takeaway points for integrating new data into your everyday practice.

A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance

Sep 30 2024 32 mins  
Listen to expert perspectives on selecting optimal therapy for patients with CLL, with a focus on how BTK inhibitor resistance mutations are assessed and how they affect therapy choice.

Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC

Sep 06 2024 13 mins  
Audio podcast with highlights from a live webinar covering available clinical data and approved treatments options for progressive ROS1-altered advanced non-small-cell lung cancer (NSCLC), including emerging options on the horizon. Listen to the experts review and discuss their perspectives and summarize the clinical data in support of guideline second-line and beyond treatments.

Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC

Sep 05 2024 13 mins  
Audio podcast with highlights from a live webinar covering available clinical data and approved treatments for ROS1-altered TKI-naive advanced non-small-cell lung cancer (NSCLC). Listen to the experts review and discuss their perspectives and summarize clinical data in support of guideline-recommended first-line treatment approaches.

ROS1-Alterations and Molecular Testing in Advanced NSCLC

Aug 28 2024 16 mins  
Audio podcast with clinical highlights from a live webinar covering current recommended molecular testing for ROS1-alterations in patients with non-small-cell lung cancer. Listen to the experts review and discuss their perspectives and summarize current best practices.

Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers

Aug 04 2024 49 mins  
Audio podcast with key clinical midyear highlights for gynecologic cancer from the 2024 SGO annual meeting on women’s cancer and the 2024 ASCO annual meeting. Listen to experts put new trial results into context and cover practical perspectives and takeaway points for your everyday practice.

Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Jul 22 2024 34 mins  
In this podcast based on a live symposium at the American Society of Clinical Oncology 2024 Annual Meeting, 3 experts discuss the current data and use of SERDs for patients with HR+/HER2- breast cancer.